Consultation Summary: Strategies to Increase Hepatitis C Treatment Within ADAPs

HRSA HIV/AIDS Bureau (HAB)

Consultation meeting regarding strategies to increase hepatitis C (HCV) treatment within ADAPs. Report features:

  • Participants in the consultation
  • Best practices in ADAP HCV treatment utilization
  • Round-robin discussions
  • Recommendations
  • Summary tables of ADAP formulary inclusion of directly-acting antiviral (DAA) HCV medications and coverage policies

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response